ATRC logo

ATRC
Atricure Inc

389
Mkt Cap
$2.11B
Volume
288,787.00
52W High
$43.11
52W Low
$28.29
PE Ratio
-69.70
ATRC Fundamentals
Price
$41.59
Prev Close
$42.38
Open
$42.40
50D MA
$35.80
Beta
1.05
Avg. Volume
542,591.68
EPS (Annual)
-$0.9517
P/B
4.42
Rev/Employee
$357,928.46
Loading...
Loading...
News
all
press releases
Abbott Gains From Lingo CGM's Expansion on Android Platform
ABT expands its Lingo biowearable to Android, broadening access to real-time glucose tracking and pushing continuous monitoring into mainstream wellness.
Zacks·4h ago
News Placeholder
More News
News Placeholder
AtriCure, Inc. $ATRC Shares Acquired by Squarepoint Ops LLC
Squarepoint Ops LLC raised its holdings in shares of AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 64.7% in the 2nd quarter, according to the company in its most recent disclosure with the Securities...
MarketBeat·8h ago
News Placeholder
ATRC Treats First Patients Using Novel Dual-Energy PFA-RFA Platform
AtriCure's first patients treated with its dual-energy PFA-RFA platform mark a key step as it moves toward a clinical trial next year.
Zacks·3d ago
News Placeholder
CBLL Gets FDA Consent for One-of-a-Kind Delirium Monitoring Solution
CeriBell gains FDA clearance for its continuous delirium monitoring solution, boosting its AI-driven EEG platform and expanding its role in critical care.
Zacks·3d ago
News Placeholder
AtriCure Announces the First Patients Treated with Novel Dual Energy Platform
AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management...
Business Wire·4d ago
News Placeholder
Are Medical Stocks Lagging AtriCure (ATRC) This Year?
Here is how AtriCure (ATRC) and Boston Scientific (BSX) have performed compared to their sector so far this year.
Zacks·7d ago
News Placeholder
Hood River Capital Management LLC Has $100.31 Million Holdings in AtriCure, Inc. $ATRC
Hood River Capital Management LLC boosted its stake in AtriCure, Inc. (NASDAQ:ATRC - Free Report) by 2.1% during the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·7d ago
News Placeholder
AtriCure, Inc. (NASDAQ:ATRC) Given Consensus Rating of "Moderate Buy" by Brokerages
Shares of AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) have received an average recommendation of "Moderate Buy" from the eleven brokerages that are covering the firm, MarketBeat reports. One...
MarketBeat·16d ago
News Placeholder
Is AtriCure Stock a Buy or Sell After a Director Dumped 10,000 Shares?
Key PointsAtriCure Board of Directors member Sven Wehrwein sold 10,000 shares in the company on Nov. 24 and 25, 2025...
Nasdaq News: Markets·16d ago
News Placeholder
AtriCure (NASDAQ:ATRC) Insider Justin Noznesky Sells 5,166 Shares
AtriCure, Inc. (NASDAQ:ATRC - Get Free Report) insider Justin Noznesky sold 5,166 shares of the company's stock in a transaction on Wednesday, November 26th. The shares were sold at an average price...
MarketBeat·18d ago
<
1
2
...
>

Latest ATRC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.